Smith, Shawna N.
Greineder, Colin F.
Errickson, Joshua
Burns, Jessica
Seagull, F Jacob
Kocher, Keith E.
Kline, Jeffrey A.
Kullgren, Jeffrey T.
Lanham, Michael S. M.
Krein, Sarah L.
Barnes, Geoffrey D. https://orcid.org/0000-0002-6532-8440
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL163438)
Article History
Received: 4 February 2025
Accepted: 16 March 2025
First Online: 2 April 2025
Declarations
:
: The University of Michigan Institutional Review Board has reviewed and approved this study, HUM00220089.
: Not applicable.
: KEK: Grant funding—Blue Cross Blue Shield of Michigan/Blue Care Network (Dr Kocher reported receiving grant funding to support the Michigan Emergency Department Improvement Collaborative during the conduct of the study). GDB: Grant Funding—Boston Scientific; Consulting—Pfizer, Bristol-Myers Squibb, Janssen, Bayer, AstraZeneca, Sanofi, Anthos, Abbott Vascular, Boston Scientific. All others have no competing interests to disclose.